Cetera Investment Advisers
GMAB icon

Cetera Investment Advisers’s Genmab GMAB Stock Holding History

Cetera Investment Advisers’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
76,454
-4,966
-6% -$132K ﹤0.01% 2346
2026
Q1 		$2.18M Sell
81,420
-2,504
-3% -$75K ﹤0.01% 2211
2025
Q4 		$2.58M Buy
83,924
+9,929
+13% +$309K ﹤0.01% 1996
2025
Q3 		$2.27M Buy
+73,995
New +$1.8M ﹤0.01% 2063
2024
Q4 		– Sell
-11,508
Closed -$281K – 3822
2024
Q3 		$281K Buy
11,508
+2,685
+30% +$71.8K ﹤0.01% 3121
2024
Q2 		$222K Sell
8,823
-2,250
-20% -$63.8K ﹤0.01% 3294
2024
Q1 		$331K Buy
+11,073
New +$325K ﹤0.01% 2949
2023
Q4 		– Sell
-7,695
Closed -$271K – 2277
2023
Q3 		$271K Sell
7,695
-805
-9% -$30.7K ﹤0.01% 1796
2023
Q2 		$323K Sell
8,500
-2,314
-21% -$92.3K ﹤0.01% 1690
2023
Q1 		$408K Sell
10,814
-6,201
-36% -$238K ﹤0.01% 1536
2022
Q4 		$721K Buy
17,015
+4,482
+36% +$185K 0.01% 1161
2022
Q3 		$403K Buy
+12,533
New +$440K 0.01% 1093
2022
Q1 		– Sell
-7,462
Closed -$295K – 1928
2021
Q4 		$295K Buy
7,462
+620
+9% +$25.9K ﹤0.01% 1499
2021
Q3 		$299K Buy
6,842
+1,815
+36% +$81.5K ﹤0.01% 1443
2021
Q2 		$205K Buy
+5,027
New +$194K ﹤0.01% 1658

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cetera Investment Advisers's GMAB Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Genmab (GMAB) stake by 6.1% in Q2 2026, selling an estimated $132K and leaving 76,454 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

Cetera Investment Advisers first reported a position in GMAB in Q2 2021 and has held it in 15 quarters since. The position peaked at $2.58M in Q4 2025. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Cetera Investment Advisers held 76,454 shares of Genmab worth $2.1M as of Q2 2026.
  • Cetera Investment Advisers sold 4,966 Genmab shares in Q2 2026, an estimated $132K.
  • Genmab made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2346 holding.
  • Cetera Investment Advisers first reported a position in Genmab in Q2 2021 and has held it in 15 quarters since.
  • Cetera Investment Advisers's Genmab position peaked at $2.58M in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.